Magali Saint Martin1,2,3,4, Emilia Sforza1,2,3, Catherine Thomas-Anterion4, Jean Claude Barthélémy1,2,3, Frédéric Roche1,2,3. 1. Département de Physiologie Clinique et de l'Exercice, Pôle Neuro-OstéoLocomoteur, Centre Hospitalo-Universitaire, Saint-Étienne, France. 2. Faculté de Médicine de Saint-Etienne, Université Jean Moulin, Saint-Étienne, France. 3. Pôle de Recherche et d'Enseignement Supérieur, Université de Lyon, Lyon, France. 4. Laboratoire des Mécanismes Cognitifs, Université de Lyon 2, Lyon, France.
Abstract
OBJECTIVES: To assess the role of the cardiac autonomic nervous system (ANS), as measured according to spontaneous cardiac baroreflex sensitivity (BRS), in the type and degree of cognitive performance in healthy young-elderly individuals, taking into account the presence of other vascular risk factors. DESIGN: Community-based cross-sectional study. SETTING: In-home and clinical settings. PARTICIPANTS: A subset of participants, aged 66.9±0.9, from a prospective study that aimed to assess the influence of ANS activity on cardiovascular and cerebrovascular morbidity and mortality (N=916). MEASUREMENTS: All subjects underwent a clinical interview, neuropsychological testing, and autonomic and vascular measurements. Three cognitive domains were defined: attentional (Trail-Making Test Part A, Stroop code and parts I & II), executive (Trail-Making Test Part B, Stroop part III, verbal fluency and similarity tests), and memory (Benton visual retention test, Grober and Buschké procedure). Subjects were stratified according to their scores into normal, low, and impaired performers. RESULTS: After adjustments to demographic and vascular data, participants with moderate autonomic dysregulation (3<BRS≤6) were determined to be 1.82 times as likely to have memory impairment (odds ratio (OR)=1.82, 95% confidence interval (CI)=1.13-3.17, P=.02) and those with severe autonomic dysregulation (BRS≤3) to be 2.65 as likely (OR=2.65, 95% CI=1.40-5.59, P=.006) as participants with normal BRS (>6). CONCLUSION: In older individuals without dementia, autonomic dysregulation seems to have a direct, gradual, and independent effect on memory. Future studies are needed to evaluate the long-term effects of BRS and other markers of the ANS on cognitive decline.
OBJECTIVES: To assess the role of the cardiac autonomic nervous system (ANS), as measured according to spontaneous cardiac baroreflex sensitivity (BRS), in the type and degree of cognitive performance in healthy young-elderly individuals, taking into account the presence of other vascular risk factors. DESIGN: Community-based cross-sectional study. SETTING: In-home and clinical settings. PARTICIPANTS: A subset of participants, aged 66.9±0.9, from a prospective study that aimed to assess the influence of ANS activity on cardiovascular and cerebrovascular morbidity and mortality (N=916). MEASUREMENTS: All subjects underwent a clinical interview, neuropsychological testing, and autonomic and vascular measurements. Three cognitive domains were defined: attentional (Trail-Making Test Part A, Stroop code and parts I & II), executive (Trail-Making Test Part B, Stroop part III, verbal fluency and similarity tests), and memory (Benton visual retention test, Grober and Buschké procedure). Subjects were stratified according to their scores into normal, low, and impaired performers. RESULTS: After adjustments to demographic and vascular data, participants with moderate autonomic dysregulation (3<BRS≤6) were determined to be 1.82 times as likely to have memory impairment (odds ratio (OR)=1.82, 95% confidence interval (CI)=1.13-3.17, P=.02) and those with severe autonomic dysregulation (BRS≤3) to be 2.65 as likely (OR=2.65, 95% CI=1.40-5.59, P=.006) as participants with normal BRS (>6). CONCLUSION: In older individuals without dementia, autonomic dysregulation seems to have a direct, gradual, and independent effect on memory. Future studies are needed to evaluate the long-term effects of BRS and other markers of the ANS on cognitive decline.
Authors: Carolina Baeza-Velasco; Caroline Bourdon; Roberto Polanco-Carrasco; Marie de Jouvencel; Marie-Christine Gely-Nargeot; Anne Gompel; Claude Hamonet Journal: Rheumatol Int Date: 2017-02-08 Impact factor: 2.631
Authors: Hannah M Tayler; Jennifer C Palmer; Taya L Thomas; Patrick G Kehoe; Julian Fr Paton; Seth Love Journal: J Cereb Blood Flow Metab Date: 2017-08-07 Impact factor: 6.200
Authors: Christopher L Schaich; Diego Malaver; Haiying Chen; Hossam A Shaltout; Adina Zeki Al Hazzouri; David M Herrington; Timothy M Hughes Journal: J Am Heart Assoc Date: 2020-03-21 Impact factor: 5.501
Authors: Michael Kühne; Christine S Zuern; Peter Hämmerle; Stefanie Aeschbacher; Anne Springer; Ceylan Eken; Michael Coslovsky; Gilles Dutilh; Giorgio Moschovitis; Nicolas Rodondi; Patricia Chocano; David Conen; Stefan Osswald Journal: Clin Res Cardiol Date: 2021-06-22 Impact factor: 5.460